Nutex Health, Inc. (NUTX)

Nutex Health, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Nutex Health, Inc. (NUTX) is a Medical - Healthcare Information Services company based in US with a market capitalization of $792.1M. Revenue grew 82.4% year-over-year and the company generated $245.6M in free cash flow. This page tracks NUTX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 800 employees · IPO Apr 4, 2022

Valuation

Valuation & price

$126.30 · as of May 17, 2026 · -35.7% vs 52w high

12.1

P/E ratio

Latest-FY diluted EPS

2.40

P/B ratio

Market cap ÷ book equity

Dividend yield

Price — last 12 months

$197$139$82.05Jul 25Dec 25Jul 26Jul 7, 25$125.73Jul 9, 25$115.70Jul 11, 25$114.61Jul 15, 25$113.73Jul 17, 25$110.78Jul 21, 25$111.19Jul 23, 25$92.90Jul 25, 25$95.02Jul 29, 25$85.41Jul 31, 25$84.81Aug 4, 25$88.89Aug 6, 25$93.59Aug 11, 25$89.63Aug 13, 25$105.19Aug 15, 25$92.91Aug 19, 25$94.96Aug 21, 25$96.18Aug 25, 25$89.51Aug 27, 25$89.78Aug 29, 25$83.79Sep 3, 25$82.05Sep 5, 25$83.38Sep 9, 25$85.90Sep 11, 25$92.00Sep 16, 25$88.08Sep 18, 25$92.96Sep 22, 25$99.71Sep 24, 25$100.31Sep 26, 25$102.53Sep 30, 25$103.32Oct 2, 25$107.19Oct 6, 25$108.62Oct 8, 25$102.74Oct 10, 25$94.83Oct 14, 25$99.47Oct 16, 25$96.70Oct 21, 25$114.50Oct 23, 25$117.30Oct 27, 25$129.48Oct 29, 25$127.83Oct 31, 25$123.06Nov 4, 25$126.71Nov 6, 25$121.74Nov 10, 25$118.86Nov 12, 25$121.65Nov 14, 25$107.11Nov 18, 25$99.20Nov 20, 25$142.34Nov 25, 25$119.21Nov 28, 25$115.11Dec 2, 25$129.77Dec 4, 25$156.79Dec 8, 25$181.06Dec 10, 25$176.47Dec 12, 25$184.89Dec 16, 25$171.72Dec 18, 25$166.84Dec 22, 25$179.55Dec 24, 25$168.10Dec 29, 25$183.88Jan 2, 26$148.19Jan 6, 26$171.95Jan 8, 26$184.11Jan 12, 26$180.72Jan 14, 26$165.90Jan 16, 26$152.77Jan 21, 26$146.97Jan 23, 26$156.21Jan 27, 26$153.81Jan 29, 26$148.53Feb 2, 26$161.25Feb 4, 26$125.10Feb 9, 26$104.64Feb 11, 26$103.00Feb 13, 26$99.71Feb 18, 26$104.51Feb 20, 26$101.08Feb 24, 26$99.19Feb 26, 26$115.77Mar 2, 26$117.60Mar 4, 26$108.44Mar 6, 26$90.28Mar 10, 26$96.78Mar 12, 26$87.01Mar 17, 26$94.01Mar 19, 26$94.66Mar 23, 26$94.98Mar 25, 26$100.38Mar 27, 26$93.81Mar 31, 26$95.04Apr 2, 26$100.92Apr 7, 26$102.90Apr 9, 26$105.70Apr 13, 26$106.27Apr 15, 26$109.00Apr 17, 26$105.58Apr 22, 26$108.39Apr 24, 26$108.24Apr 28, 26$115.09Apr 30, 26$119.20May 4, 26$147.17May 6, 26$130.59May 8, 26$136.66May 12, 26$135.48May 14, 26$127.84May 18, 26$124.70May 20, 26$121.54May 22, 26$118.91May 28, 26$130.58Jun 1, 26$128.02Jun 3, 26$132.83Jun 5, 26$132.59Jun 9, 26$135.40Jun 11, 26$147.01Jun 15, 26$147.08Jun 17, 26$146.38Jun 22, 26$150.17Jun 24, 26$147.54Jun 26, 26$166.40Jul 2, 26$196.53
$80.9252-week range$196.53
Loading valuation history…

Fundamentals

Key fundamentals

$792.1M

Market cap

82.4%

Revenue growth (YoY)

50.8%

Gross margin

$245.6M

Free cash flow (USD)

$165.8M

Net debt

24.7%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

20162025

FY 2016$0.00FY 2017$53.6KFY 2018$91.4KFY 2019$97.1MFY 2020$274.0MFY 2021$331.5MFY 2022$219.3MFY 2023$247.6MFY 2024$479.9MFY 2025$875.3M
$0$875.3M

Free cash flow by year

20162025

FY 2016$-274.2KFY 2017$-714.6KFY 2018$-480.0KFY 2019$-20.2MFY 2020$25.5MFY 2021$136.5MFY 2022$36.0MFY 2023$-8.2MFY 2024$20.8MFY 2025$245.6M
-$274.2K$245.6M

Gross margin by year

20212025

FY 202154.1%FY 20227.0%FY 202314.0%FY 202440.9%FY 202550.8%
54.1%50.8%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed Apr 30, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Quarterly report10-Q FiledApr 30, 2026Filing
  • 8-K eventEarnings ReleaseApr 30, 2026Filing
  • 8-K eventAnnual Meeting ResultsApr 23, 2026Filing

Questions

Frequently asked questions

What is Nutex Health, Inc.'s market cap?

Nutex Health, Inc. (NUTX) has a market capitalization of $792.1M.

What is NUTX's P/E ratio?

NUTX trades at a price-to-earnings ratio of 12.1, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is NUTX's price-to-book (P/B) ratio?

NUTX trades at 2.40 times book value per share.

Are insiders buying NUTX stock?

SEC Form 4 filings show no open-market insider buys at Nutex Health, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Healthcare Information Services

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.